Evidence map›Paper›PMID 32041178›Full record

ArticleInternational journal of molecular sciences2020

An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.

Daniel Missailidis, Sarah J Annesley, Claire Y Allan, Oana Sanislav, Brett A Lidbury, Donald P Lewis, Paul R Fisher

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04592354 (Anhydrous Enol-Oxaloacetate), which is not on this map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04592354 naunknown statusnot on this map

Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors

TypeinterventionalSponsorTerra Biological LLCRan2020 to 2021Enrolled40ConditionsTreatment of Fatigue After Resolution of COVID-19 InfectionArmsOxaloacetate Medical Food/Dietary Supplement
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.Health technology assessment (Winchester, England) · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel MissailidisDepartment of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
Sarah J AnnesleyDepartment of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.ORCID 0000-0002-7604-3985
Claire Y AllanDepartment of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
Oana SanislavDepartment of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
Brett A LidburyNational Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT 2601, Australia.ORCID 0000-0003-2211-989X
Donald P Lewis
Paul R FisherDepartment of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.ORCID 0000-0003-1884-6306
La Trobe University · AUAustralian National University · AU

Funding

Judith Jane Mason and Harold Stannett Williams Memorial Foundation MAS2016F063Judith Jane Mason and Harold Stannett Williams Memorial Foundation MAS2018F00026McCusker Charitable Foundation NA
6 · The paper itself

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an enigmatic condition characterized by exacerbation of symptoms after exertion (post-exertional malaise or "PEM"), and by fatigue whose severity and associated requirement for rest are excessive and disproportionate to the fatigue-inducing activity. There is no definitive molecular marker or known underlying pathological mechanism for the condition. Increasing evidence for aberrant energy metabolism suggests a role for mitochondrial dysfunction in ME/CFS. Our objective was therefore to measure mitochondrial function and cellular stress sensing in actively metabolizing patient blood cells. We immortalized lymphoblasts isolated from 51 ME/CFS patients diagnosed according to the Canadian Consensus Criteria and an age- and gender-matched control group. Parameters of mitochondrial function and energy stress sensing were assessed by Seahorse extracellular flux analysis, proteomics, and an array of additional biochemical assays. As a proportion of the basal oxygen consumption rate (OCR), the rate of ATP synthesis by Complex V was significantly reduced in ME/CFS lymphoblasts, while significant elevations were observed in Complex I OCR, maximum OCR, spare respiratory capacity, nonmitochondrial OCR and "proton leak" as a proportion of the basal OCR. This was accompanied by a reduction of mitochondrial membrane potential, chronically hyperactivated TOR Complex I stress signaling and upregulated expression of mitochondrial respiratory complexes, fatty acid transporters, and enzymes of the β-oxidation and TCA cycles. By contrast, mitochondrial mass and genome copy number, as well as glycolytic rates and steady state ATP levels were unchanged. Our results suggest a model in which ME/CFS lymphoblasts have a Complex V defect accompanied by compensatory upregulation of their respiratory capacity that includes the mitochondrial respiratory complexes, membrane transporters and enzymes involved in fatty acid β-oxidation. This homeostatically returns ATP synthesis and steady state levels to "normal" in the resting cells, but may leave them unable to adequately respond to acute increases in energy demand as the relevant homeostatic pathways are already activated.

Indexed as

Adenosine TriphosphateAdultAgedCanadaCell Culture TechniquesCell ProliferationCells, CulturedCell SurvivalEnergy MetabolismFatigue Syndrome, ChronicFemaleHumansLymphocytesMaleMechanistic Target of Rapamycin Complex 1Middle AgedAdenosine TriphosphateMechanistic Target of Rapamycin Complex 1Mitochondrial Proton-Translocating ATPasesoligomycin sensitivity-conferring proteinchronic fatigue syndromeComplex Vmitochondriamyalgic encephalomyelitisseahorse respirometryTORC1

Identifiers

PMID32041178
PMCPMC7036826
OpenAlexW2972236099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.